Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-70
SponsorNational Taiwan University Hospital

About this trial

This is a randomized double-blind sham-controlled crossover study; the interventions are high-frequency rTMS stimulation on left DLPFC and sham control. The study population is the patient with somatic symptom disorder. The primary outcomes are somatic distress and health anxiety.

Eligibility criteria

Qualifiers

Patient with somatic symptom disorder (confirmed by psychiatrists)

Age 20-70

Disqualifiers

Having psychotic symptoms or cognitive impairment

Having potentially lethal illness

Using cardiac pacemakers or defibrillators

Currently pregnant or having plans to become pregnant within the next three months

Trial design

Treatments tested in this trial

  • Repetitive transcranial magnetic stimulation
  • Sham stimulation

Treatment groups

30 Participants
are divided into 2 treatment groups